文献速递产科母胎医学

先天性弓形虫病:预防胎儿感染的药物预防证据

Congenital toxoplasmosis: What is the evidence for chemoprophylaxis to prevent fetal infection?
PubMed 文献 · Prenat Diagn · 2020-06-29

综述探讨先天性弓形虫病产前预防胎盘传播的效果争议,涉及螺旋霉素与乙胺嘧啶+磺胺联合方案。观察性研究存在治疗偏倚,但及时治疗后传播率较低;

要点

  • 母体感染后存在预防胎盘传播的「机会窗口」,应尽快启动预防性治疗。
  • P-S组胎儿脑超声征象发生率显著降低。

核心结论

  • 母体感染后快速启动预防性治疗可能降低胎盘传播,但现有证据受治疗偏倚影响。

研究设计与样本

  • 综述纳入实验、寄生虫学和临床数据,评估螺旋霉素(Spy)与乙胺嘧啶+磺胺联合方案(P-S)预防胎盘传播的效果。
  • 证据包括观察性研究(存在治疗偏倚)和唯一一项随机对照试验。

主要发现

  • 部分大型回顾性研究未发现预防性治疗与传播差异,但母体血清转化后及时治疗者传播较低。
  • 少数近期研究调整感染时机后发现P-S较其他或无预防传播更低。

关键数值与推荐

  • 治疗在血清转化后3周内启动时,P-S与较低传播的关联更强。
  • P-S组胎儿脑超声征象发生率显著降低。

临床怎么用

  • 母体感染后应尽快启动预防性治疗,以利用「机会窗口」降低胎盘传播。
  • 因母体感染常无症状,需系统筛查孕期血清转化以识别治疗时机。

局限性

  • 观察性研究存在治疗偏倚,处方因血清转化时孕周(主要传播风险因素)而异且多缺乏精确时机。
  • 仅有一项随机对照试验,证据有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Although prenatal diagnosis and prenatal and neonatal therapy of congenital toxoplasmosis are available, there is controversy concerning the effectiveness of prophylaxis to prevent placental transmission. Experimental, parasitological, and clinical data suggest a "window of opportunity" following maternal infection. Among medications active against Toxoplasma gondii, mainly spiramycin (Spy) and pyrimethamine + sulfonamide combinations (P-S) have been evaluated. Results from observational studies suffered treatment bias, since prescriptions differed according to the gestational age at seroconversion, which is the major risk factor for transmission, and many lacked precise timing. Some large retrospective studies found no difference in transmission according to prophylactic treatment, but transmission was lower when treatment started promptly after maternal seroconversion. A few recent studies adjusting for timing of infection observed lower transmission in case of P-S than other or no prophylaxis. In the only randomized controlled trial, transmission was lower with P-S than S (18.5% vs 30%, P = .147); this association was strengthened when the treatment was started within 3 weeks of seroconversion, and the incidence of fetal cerebral ultrasound signs was significantly reduced in the P-S group. Rapid initiation of prophylactic therapy following maternal infection, which is usually asymptomatic, requires systematic screening for maternal seroconversion during pregnancy.

来源:Prenat Diagn,查看原文。版权归原作者所有。

引用

  1. Mandelbrot L. Congenital toxoplasmosis: What is the evidence for chemoprophylaxis to prevent fetal infection? Prenat Diagn. 2020. PMID: 32453454. doi:10.1002/pd.5758

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。